We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSET icon
2901
Bassett Furniture
BSET
$176M
$218K ﹤0.01%
+8,961
New +$262K
INZY
2902
DELISTED
Inozyme Pharma
INZY
$218K ﹤0.01%
+12,787
New +$222K
KG
2903
Kestrel Group
KG
$69.7M
$218K ﹤0.01%
+3,237
New +$225K
PLSE icon
2904
Pulse Biosciences
PLSE
$2.65B
$218K ﹤0.01%
13,300
-1,087
-8% -$20.7K
HBB icon
2905
Hamilton Beach Brands
HBB
$366M
$216K ﹤0.01%
9,692
-975
-9% -$21.3K
HYRE
2906
DELISTED
HyreCar Inc. Common Stock
HYRE
$216K ﹤0.01%
+10,329
New +$159K
VOR icon
2907
Vor Biopharma
VOR
$1.28B
$215K ﹤0.01%
577
+97
+20% +$47.9K
DLTH icon
2908
Duluth Holdings
DLTH
$158M
$214K ﹤0.01%
10,356
-5,951
-36% -$98.2K
INFI
2909
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$214K ﹤0.01%
+71,539
New +$226K
MELI icon
2910
Mercado Libre
MELI
$92.8B
$212K ﹤0.01%
136
-10
-7% -$14.7K
XOMA
2911
DELISTED
Xoma
XOMA
$212K ﹤0.01%
6,227
+819
+15% +$27.4K
GWRS icon
2912
Global Water Resources
GWRS
$215M
$211K ﹤0.01%
12,361
-1,249
-9% -$21.2K
KZR
2913
DELISTED
Kezar Life Sciences
KZR
$211K ﹤0.01%
3,885
-214
-5% -$12.2K
NGMS
2914
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$211K ﹤0.01%
+3,426
New +$179K
VEI
2915
DELISTED
Vine Energy Inc.
VEI
$209K ﹤0.01%
+13,432
New +$185K
ACET icon
2916
Adicet Bio
ACET
$74.1M
$208K ﹤0.01%
+1,266
New +$258K
FBIO icon
2917
Fortress Biotech
FBIO
$92M
$208K ﹤0.01%
3,877
+314
+9% +$18.9K
CCRD
2918
DELISTED
CoreCard
CCRD
$205K ﹤0.01%
6,525
-475
-7% -$16.9K
BOLT icon
2919
Bolt Biotherapeutics
BOLT
$7.44M
$204K ﹤0.01%
660
+121
+22% +$49.1K
INDT
2920
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$204K ﹤0.01%
+3,112
New +$199K
KNTK icon
2921
Kinetik
KNTK
$3.69B
$202K ﹤0.01%
+5,998
New +$190K
HARP
2922
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$202K ﹤0.01%
1,456
+422
+41% +$80.5K
PSTL
2923
Postal Realty Trust
PSTL
$689M
$200K ﹤0.01%
+10,988
New +$214K
HOFV
2924
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$198K ﹤0.01%
+2,289
New +$198K
HBIO icon
2925
Harvard Bioscience
HBIO
$27.9M
$196K ﹤0.01%
2,351
-1,948
-45% -$138K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.